Hassan Fred bought RXRX
November 2, 2026 · Form 4 insider transaction
Hassan Fred bought 156,658 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
156,658
Price
$0.00
Total value
N/A
InsiderHassan Fred
RoleDirector
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateNovember 2, 2026
Filing dateNovember 4, 2026
Shares owned after156,658
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a grant of restricted stock units automatically granted pursuant to Recursion's Outside Director Compensation Policy. The restricted stock units will vest as to 1/3rd of the shares subject to the award on the first three anniversaries of November 2, 2026, subject to the Reporting Person continuing to be a service provider through the applicable vesting dates.